soluble IL-17RC (Merck Serono)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namesoluble IL-17RC (Merck Serono)
Drug Alias Namesoluble IL-17RC (Zymogenetics)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInterleukin-17 receptors modulatorsInterleukin-17 inhibitors
TargetsInterleukin-17 receptorsInterleukin-17
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesWorld
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZymogenetics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Serono SaZymogenetics Inc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A